Known sensitivity to PROVERA tablets.
Undiagnosed vaginal bleeding.
Liver dysfunction or active liver disease; Thrombophlebitis, thromboembolic disorders or cerebral apoplexy, or patients with a past history of these conditions.
Pregnancy (either for diagnosis or therapy), see Warnings.
10 mg: Patients with carcinoma of breast of reproductive organs (known or suspected to be estrogen-dependent).
Additional Contraindication(s) for Specific Use: Contraception/Gynecology: Known or suspected malignancy of breast.
100 mg: Undiagnosed urinary tract bleeding.
Undiagnosed breast pathology.